Likewise, carcinoembryonic antigen (CEA) has also been used as a target in colorectal cancer; however, the administration of T cells expressing a CEA-specific T cell receptor (TCR) to patients induced severe colitis targeting intestinal CEA, thus limiting its potential [6]. Here, CEACAM5 is linked to colitis.